QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online May 5, 2004
doi: 10.1242/10.1242/dev.01131

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nath, A. K. Articles by Pinter, E. Search for Related Content PubMed PubMed Citation Articles by Nath, A. K. Articles by Pinter, E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE NITRIC OXIDE Social Bookmarking                         What's this?

Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy

¹ Department of Molecular, Cellular and Developmental Biology, Yale University School of Medicine, New Haven, CT 06520, USA
² Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
³ Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06510, USA
⁴ Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, USA

^* Author for correspondence (e-mail: joseph.madri{at}yale.edu)

Accepted 4 February 2004

Nitric oxide (NO) has been demonstrated to mediate events during ovulation, pregnancy, blastocyst invasion and preimplantation embryogenesis. However, less is known about the role of NO during postimplantation development. Therefore, in this study, we explored the effects of NO during vascular development of the murine yolk sac, which begins shortly after implantation. Establishment of the vitelline circulation is crucial for normal embryonic growth and development. Moreover, functional inactivation of the endodermal layer of the yolk sac by environmental insults or genetic manipulations during this period leads to embryonic defects/lethality, as this structure is vital for transport, metabolism and induction of vascular development. In this study, we describe the temporally/spatially regulated distribution of nitric oxide synthase (NOS) isoforms during the three stages of yolk sac vascular development (blood island formation, primary capillary plexus formation and vessel maturation/remodeling) and found NOS expression patterns were diametrically opposed. To pharmacologically manipulate vascular development, an established in vitro system of whole murine embryo culture was employed. During blood island formation, the endoderm produced NO and inhibition of NO (L-NMMA) at this stage resulted in developmental arrest at the primary plexus stage and vasculopathy. Furthermore, administration of a NO donor did not cause abnormal vascular development; however, exogenous NO correlated with increased eNOS and decreased iNOS protein levels. Additionally, a known environmental insult (high glucose) that produces reactive oxygen species (ROS) and induces vasculopathy also altered eNOS/iNOS distribution and induced NO production during yolk sac vascular development. However, administration of a NO donor rescued the high glucose induced vasculopathy, restored the eNOS/iNOS distribution and decreased ROS production. These data suggest that NO acts as an endoderm-derived factor that modulates normal yolk sac vascular development, and decreased NO bioavailability and NO-mediated sequela may underlie high glucose induced vasculopathy.

Key words: Nitric oxide, Vasculogenesis, Yolk sac, Hyperglycemia, Reactive oxygen species, Mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A.-M. Teichert, J. A. Scott, G. B. Robb, Y.-Q. Zhou, S.-N. Zhu, M. Lem, A. Keightley, B. M. Steer, A. C. Schuh, S. L. Adamson, et al. Endothelial Nitric Oxide Synthase Gene Expression During Murine Embryogenesis: Commencement of Expression in the Embryo Occurs With the Establishment of a Unidirectional Circulatory System Circ. Res., July 3, 2008; 103(1): 24 - 33. [Abstract] [Full Text] [PDF]

				A. Schmidt, K. Brixius, and W. Bloch Endothelial Precursor Cell Migration During Vasculogenesis Circ. Res., July 20, 2007; 101(2): 125 - 136. [Abstract] [Full Text] [PDF]

				S. Ahmad, P. W. Hewett, P. Wang, B. Al-Ani, M. Cudmore, T. Fujisawa, J. J. Haigh, F. le Noble, L. Wang, D. Mukhopadhyay, et al. Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide-Mediated Angiogenesis Circ. Res., September 29, 2006; 99(7): 715 - 722. [Abstract] [Full Text] [PDF]

				Z. Zhao and E. A. Reece Experimental Mechanisms of Diabetic Embryopathy and Strategies for Developing Therapeutic Interventions Reproductive Sciences, December 1, 2005; 12(8): 549 - 557. [Abstract] [PDF]

				A Jawerbaum, R Higa, V White, E Capobianco, C Pustovrh, D Sinner, N Martinez, and E Gonzalez Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis Reproduction, November 1, 2005; 130(5): 695 - 703. [Abstract] [Full Text] [PDF]

				C. Patterson Even Flow: Shear Cues Vascular Development Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1761 - 1762. [Full Text] [PDF]